{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:15:35Z","timestamp":1793812535359,"version":"4.6.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:00:00Z","timestamp":1661040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:00:00Z","timestamp":1661040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The presence of micropapillary and solid adenocarcinoma patterns leads to a worse survival and a significantly higher tendency to recur. This study aims to assess the impact of pT descriptor combined with the presence of high-grade components on long-term outcomes in early-stage lung adenocarcinomas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively collected data of consecutive resected pT1-T3N0 lung adenocarcinoma from nine European Thoracic Centers. All patients who underwent a radical resection with lymph-node dissection between 2014 and 2017 were included. Differences in Overall Survival (OS) and Disease-Free Survival (DFS) and possible prognostic factors associated with outcomes were evaluated also after performing a propensity score matching to compare tumors containing non-high-grade and high-grade patterns.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 607 patients, the majority were male and received a lobectomy. At least one high-grade histological pattern was seen in 230 cases (37.9%), of which 169 solid and 75 micropapillary. T1a-b-c without high-grade pattern had a significant better prognosis compared to T1a-b-c with high-grade pattern (<jats:italic>p<\/jats:italic>\u2009=\u20090.020), but the latter had similar OS compared to T2a (<jats:italic>p<\/jats:italic>\u2009=\u20090.277). Concurrently, T1a-b-c without micropapillary or solid patterns had a significantly better DFS compared to those with high-grade patterns (<jats:italic>p<\/jats:italic>\u2009=\u20090.034), and it was similar to T2a (<jats:italic>p<\/jats:italic>\u2009=\u20090.839). Multivariable analysis confirms the role of T descriptor according to high-grade pattern both for OS (<jats:italic>p<\/jats:italic>\u2009=\u20090.024; HR 1.285 95% CI 1.033\u20131.599) and DFS (<jats:italic>p<\/jats:italic>\u2009=\u20090.003; HR 1.196, 95% CI 1.054\u20131.344, respectively). These results were confirmed after the propensity score matching analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>pT1 lung adenocarcinomas with a high-grade component have similar prognosis of pT2a tumors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00408-022-00561-y","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T10:02:51Z","timestamp":1661076171000},"page":"649-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis"],"prefix":"10.1007","volume":"200","author":[{"given":"Pietro","family":"Bertoglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Aprile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Nachira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Lococo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rodriguez","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Guerrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Querzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bocchialini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bacchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Franzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Rindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Bellafiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Femia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Salvatore","family":"Bogina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Solli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kestenholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ruffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Paci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Margaritora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Selenito","family":"Imperatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Gnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Claudio","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,21]]},"reference":[{"issue":"2","key":"561_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","volume":"6","author":"WD Travis","year":"2011","unstructured":"Travis WD, Brambilla E, Noguchi M et al (2011) International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6(2):244\u2013285","journal-title":"J Thorac Oncol"},{"issue":"13","key":"561_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1200\/JCO.2011.37.2185","volume":"30","author":"A Warth","year":"2012","unstructured":"Warth A, Muley T, Meister M et al (2012) The novel histologic International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30(13):1438\u20131446","journal-title":"J Clin Oncol"},{"issue":"9","key":"561_CR3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/JTO.0b013e318221f701","volume":"6","author":"PA Russell","year":"2011","unstructured":"Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA (2011) Does lung adenocarcinoma subtype predict patient survival?: a clinicopathologic study based on the new International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 6(9):1496\u20131504","journal-title":"J Thorac Oncol"},{"issue":"5","key":"561_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/modpathol.2010.232","volume":"24","author":"A Yoshizawa","year":"2011","unstructured":"Yoshizawa A, Motoi N, Riely GJ et al (2011) Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 24(5):653\u2013664","journal-title":"Mod Pathol"},{"key":"561_CR5","first-page":"886","volume":"15","author":"P Bertoglio","year":"2020","unstructured":"Bertoglio P, Querzoli G, Ventura L et al (2020) Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database. J Surg Oncol 15:886","journal-title":"J Surg Oncol"},{"issue":"7","key":"561_CR6","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/JTO.0000000000000559","volume":"10","author":"R Rami-Porta","year":"2015","unstructured":"Rami-Porta R, Bolejack V, Crowley J et al (2015) The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 10(7):990\u20131003","journal-title":"J Thorac Oncol"},{"issue":"12","key":"561_CR7","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.6004\/jnccn.2019.0059","volume":"17","author":"DS Ettinger","year":"2019","unstructured":"Ettinger DS, Wood DE, Aggarwal C et al (2019) NCCN guidelines insights: non-small cell lung cancer, version 1.2020. J Natl Compr Canc Netw 17(12):1464\u20131472","journal-title":"J Natl Compr Canc Netw"},{"key":"561_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/JTO.0b013e3181b27799","volume":"4","author":"E Valli\u00e8res","year":"2009","unstructured":"Valli\u00e8res E, Shepherd FA, Crowley J et al (2009) The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 4:1049\u20131059","journal-title":"J Thorac Oncol"},{"issue":"1","key":"561_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.lungcan.2005.01.001","volume":"49","author":"R Rami-Porta","year":"2005","unstructured":"Rami-Porta R, Wittekind C, Goldstraw P (2005) International association for the study of lung cancer (IASLC) staging committee: complete resection in lung cancer surgery: proposed definition. Lung Cancer 49(1):25\u201333","journal-title":"Lung Cancer"},{"issue":"1","key":"561_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JTO.0b013e3182769aa8","volume":"8","author":"A Yoshizawa","year":"2013","unstructured":"Yoshizawa A, Sumiyoshi S, Sonobe M et al (2013) Validation of the IASLC\/ATS\/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 8(1):52\u201361","journal-title":"J Thorac Oncol"},{"issue":"1","key":"561_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jtho.2018.09.005","volume":"14","author":"T Eguchi","year":"2019","unstructured":"Eguchi T, Kameda K, Lu S et al (2019) Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score-matched analysis. J Thorac Oncol 14(1):87\u201398","journal-title":"J Thorac Oncol"},{"issue":"12","key":"561_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jtho.2017.08.015","volume":"12","author":"K Masai","year":"2017","unstructured":"Masai K, Sakurai H, Sukeda A et al (2017) Prognostic impact of margin distance and tumor spread through air spaces in limited resection for primary lung cancer. J Thorac Oncol 12(12):1788\u20131797","journal-title":"J Thorac Oncol"},{"issue":"4","key":"561_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/JTO.0000000000000446","volume":"10","author":"EE Duhig","year":"2015","unstructured":"Duhig EE, Dettrick A, Godbolt DB et al (2015) Mitosis trumps T stage and proposed international association for the study of lung cancer\/american thoracic society\/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma. J Thorac Oncol 10(4):673\u2013681","journal-title":"J Thorac Oncol"},{"issue":"2","key":"561_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.5601","volume":"156","author":"GD Jones","year":"2021","unstructured":"Jones GD, Brandt WS, Shen R et al (2021) A genomic-pathologic annotated risk model to predict recurrence in early-stage lung adenocarcinoma. JAMA Surg 156(2):e205601","journal-title":"JAMA Surg"},{"issue":"2","key":"561_CR15","first-page":"218","volume":"51","author":"M Ito","year":"2017","unstructured":"Ito M, Miyata Y, Yoshiya T et al (2017) Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma. Eur J Cardiothorac Surg 51(2):218\u2013222","journal-title":"Eur J Cardiothorac Surg"},{"issue":"22","key":"561_CR16","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1200\/JCO.2013.50.1049","volume":"32","author":"JJ Hung","year":"2014","unstructured":"Hung JJ, Yeh YC, Jeng WJ et al (2014) Predictive value of the international association for the study of lung cancer\/American Thoracic Society\/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival. J Clin Oncol 32(22):2357\u20132364","journal-title":"J Clin Oncol"},{"issue":"10","key":"561_CR17","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","volume":"15","author":"AL Moreira","year":"2020","unstructured":"Moreira AL, Ocampo PSS, Xia Y et al (2020) A grading system for invasive pulmonary adenocarcinoma: a proposal from the international association for the study of lung cancer pathology committee. J Thorac Oncol 15(10):1599\u20131610","journal-title":"J Thorac Oncol"},{"issue":"8","key":"561_CR18","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/PAS.0b013e3181e4ee32","volume":"34","author":"G Sica","year":"2010","unstructured":"Sica G, Yoshizawa A, Sima CS et al (2010) A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 34(8):1155\u20131162","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"561_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.lungcan.2014.05.014","volume":"85","author":"M Ito","year":"2014","unstructured":"Ito M, Miyata Y, Kushitani K et al (2014) Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC\/ATS\/ERS classifications. Lung Cancer 85(2):270\u2013275","journal-title":"Lung Cancer"},{"issue":"5","key":"561_CR20","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.athoracsur.2016.04.087","volume":"102","author":"T Yoshiya","year":"2016","unstructured":"Yoshiya T, Mimae T, Tsutani Y et al (2016) Prognostic role of subtype classification in small-sized pathologic N0 invasive lung adenocarcinoma. Ann Thorac Surg 102(5):1668\u20131673","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"561_CR21","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1097\/JTO.0b013e31829f09a7","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wu J, Tan Q, Zhu L, Gao W (2013) Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC\/ATS\/ERS classification. J Thorac Oncol 8(9):1196\u20131202","journal-title":"J Thorac Oncol"},{"issue":"30","key":"561_CR22","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1200\/JCO.2014.58.8335","volume":"33","author":"MS Tsao","year":"2015","unstructured":"Tsao MS, Marguet S, Le Teuff G et al (2015) Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection. J Clin Oncol 33(30):3439\u20133446","journal-title":"J Clin Oncol"},{"issue":"9","key":"561_CR23","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00432-016-2192-6","volume":"142","author":"J Luo","year":"2016","unstructured":"Luo J, Huang Q, Wang R et al (2016) Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB. J Cancer Res Clin Oncol 142(9):2031\u20132040","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"561_CR24","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.21037\/jtd.2018.08.64","volume":"10","author":"M Ma","year":"2018","unstructured":"Ma M, She Y, Ren Y et al (2018) Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma. J Thorac Dis 10(9):5384\u20135393","journal-title":"J Thorac Dis"},{"issue":"6","key":"561_CR25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1245\/s10434-019-08113-0","volume":"27","author":"C Wang","year":"2020","unstructured":"Wang C, Yang J, Lu M (2020) Micropapillary predominant lung adenocarcinoma in stage IA benefits from adjuvant chemotherapy. Ann Surg Oncol 27(6):2051\u20132060","journal-title":"Ann Surg Oncol"},{"issue":"10335","key":"561_CR26","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","volume":"399","author":"H Saji","year":"2022","unstructured":"Saji H, Okada M, Tsuboi M et al (2022) West Japan Oncology Group and Japan Clinical Oncology Group: Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 399(10335):1607\u20131617","journal-title":"Lancet"},{"issue":"4","key":"561_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jso.24884","volume":"117","author":"V Aprile","year":"2018","unstructured":"Aprile V, Bertoglio P, Dini P et al (2018) Is left upper lobectomy always worthwhile for early stage lung cancer? A comparison between left upper lobectomy, trisegmentectomy, and lingulectomy. J Surg Oncol 117(4):618\u2013624","journal-title":"J Surg Oncol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-022-00561-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-022-00561-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-022-00561-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T16:04:36Z","timestamp":1664640276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-022-00561-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,21]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1007\/s00408-022-00561-y","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,21]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All patients signed an informed consent for publication of data for the present study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"This study was approved by the ethical committee of Verona and Rovigo, Italy on the 13th of February 2019 (Protocol Number 8543).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}